Advisor Group’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Advisor Group’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100	Closed	–	–	5554
2019 Q2	$0	Buy	+100	New	+$111	﹤0.01%	5496
2017 Q4	–	Sell	-594	Closed	-$4K	–	5153
2017 Q3	$4K	Hold	594	–	–	﹤0.01%	4393
2017 Q2	$5K	Hold	594	–	–	﹤0.01%	4271
2017 Q1	$6K	Hold	594	–	–	﹤0.01%	4072
2016 Q4	$5K	Buy	+594	New	+$5.26K	﹤0.01%	3970

Other funds holding NVLN

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

David M. Knott $264M AUM 59.23% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading

Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return